文献速递细菌感染、耐药与抗菌药物医院感染防控

耐万古霉素肠球菌血流感染与急性白血病及骨髓增生异常综合征患者造血干细胞移植后死亡率增加相关:多中心回顾性队列研究

Bloodstream Infection Due to Vancomycin-resistant Enterococcus Is Associated With Increased Mortality After Hematopoietic Cell Transplantation for Acute Leukemia and Myelodysplastic Syndrome: A Multicenter, Retrospective Cohort Study.
PubMed 文献 · Clin Infect Dis · 2019-01-01

该多中心回顾性队列研究基于国际血液和骨髓移植研究中心数据库,分析了2008至2012年首次接受异基因造血干细胞移植的7128例急性白血病或骨髓增生异常综合征患者。

要点

  • VRE血流感染与移植后1年总生存率降低独立相关(RR 2.9)。
  • VRE血流感染与移植后1年非复发死亡率升高独立相关(RR 4.7)。
  • VRE血流感染中位发生时间为移植后第11天,早于非VRE血流感染。

核心结论

  • VRE血流感染与异基因造血干细胞移植后最低的总生存率和最高的非复发死亡率相关。

研究设计与样本

  • 多中心回顾性队列研究,利用国际血液和骨髓移植研究中心数据库,纳入2008至2012年首次接受异基因造血干细胞移植的7128例急性白血病或骨髓增生异常综合征成人和儿童患者。

主要发现

  • 7128例患者中,258例(3.2%)发生VRE血流感染,2398例(33.6%)发生非VRE血流感染,4472例(63%)无血流感染。
  • VRE血流感染和非VRE血流感染的中位发生时间分别为第11天和第15天。
  • 与非VRE血流感染患者相比,VRE血流感染患者年龄更大、急性白血病分期更晚,且更多接受脐带血移植。

临床怎么用

  • 对于异基因造血干细胞移植后发生VRE血流感染的患者,应认识到其1年总生存率显著降低且非复发死亡率显著升高,需加强监测和干预。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: We examined the impact of vancomycin-resistant Enterococcus (VRE) bloodstream infection (BSI) on outcomes of allogeneic hematopoietic cell transplantation (HCT) utilizing the Center for International Blood and Marrow Transplant Research database. METHODS: Adult and pediatric patients (N = 7128) who underwent first HCT for acute leukemia or myelodysplastic syndrome from 2008 through 2012 were analyzed as 3 groups-VRE BSI, non-VRE BSI, without BSI-according to BSI status at 100 days (D100) after allogeneic HCT. Multivariable models examined the effect of VRE BSI for overall survival (OS) and nonrelapse mortality (NRM) at 1 year. RESULTS: Of 7128 patients, 258 (3.2%) had VRE BSI, 2398 (33.6%) had non-VRE BSI, and 4472 (63%) had no BSI. The median time to VRE BSI and non-VRE BSI were D11 and D15, respectively. Compared with non-VRE BSI patients, VRE BSI patients were older, had advanced-stage acute leukemia, and received umbilical cord blood (UCB) allografts. In multivariable models, VRE BSI was associated with lower OS (relative risk [RR], 2.9;(99% confidence interval [CI], 2.2-3.7) and increased NRM (RR, 4.7; 99% CI, 3.6-6.2) (P < .0001) for both. Other predictors for worse OS and increased NRM were non-VRE BSI, older age, advanced disease stage, UCB allograft, - mismatch, comorbidity index ≥3, and cytomegalovirus seropositivity (P < .001 for all variables). CONCLUSIONS: VRE BSI is associated with lowest OS and highest NRM compared with patients without BSI or non-VRE BSI. Novel interventions that address the pathophysiology of VRE BSI have the potential of improving survival after HCT.

来源:Clin Infect Dis,查看原文。版权归原作者所有。

引用

  1. Papanicolaou GA, Ustun C, Young JH, et al. Bloodstream Infection Due to Vancomycin-resistant Enterococcus Is Associated With Increased Mortality After Hematopoietic Cell Transplantation for Acute Leukemia and Myelodysplastic Syndrome: A Multicenter, Retrospective Cohort Study. Clin Infect Dis. 2019. PMID: 30649224. doi:10.1093/cid/ciz031

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。